Global Loratadine Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
According to APO Research, The global Loratadine Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Loratadine Tablets include Anhui Guosen Pharmaceutical Co., Ltd., Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Heilongjiang Nuojie Pharmaceutical Co., Ltd., Hubei Minkang Pharmaceutical Co., Ltd., Hunan Erkang Pharmaceutical Co., Ltd. and Hunan Zhongnan Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Loratadine Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Loratadine Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Loratadine Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Loratadine Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Loratadine Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Loratadine Tablets sales, projected growth trends, production technology, application and end-user industry.
Loratadine Tablets Segment by Company
Anhui Guosen Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Heilongjiang Nuojie Pharmaceutical Co., Ltd.
Hubei Minkang Pharmaceutical Co., Ltd.
Hunan Erkang Pharmaceutical Co., Ltd.
Hunan Zhongnan Pharmaceutical Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
Sancai Shiqi Pharmaceutical Co., Ltd.
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Shanxi Xinyu Pharmaceutical Co., Ltd.
Sichuan Deyuan Pharmaceutical Group Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Tonghua Great Wall Pharmaceutical Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
Yunnan Longfa Pharmaceutical Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Loratadine Tablets Segment by Type
20 mg/Tablet
40 mg/Tablet
60 mg/Tablet
Loratadine Tablets Segment by Application
Hospital
Pharmacy
Online e-commerce
Other
Loratadine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Loratadine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loratadine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Loratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Loratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Loratadine Tablets market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Loratadine Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Loratadine Tablets include Anhui Guosen Pharmaceutical Co., Ltd., Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd., Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Heilongjiang Nuojie Pharmaceutical Co., Ltd., Hubei Minkang Pharmaceutical Co., Ltd., Hunan Erkang Pharmaceutical Co., Ltd. and Hunan Zhongnan Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Loratadine Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Loratadine Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Loratadine Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Loratadine Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Loratadine Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Loratadine Tablets sales, projected growth trends, production technology, application and end-user industry.
Loratadine Tablets Segment by Company
Anhui Guosen Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
Heilongjiang Nuojie Pharmaceutical Co., Ltd.
Hubei Minkang Pharmaceutical Co., Ltd.
Hunan Erkang Pharmaceutical Co., Ltd.
Hunan Zhongnan Pharmaceutical Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
Sancai Shiqi Pharmaceutical Co., Ltd.
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
Shanxi Xinyu Pharmaceutical Co., Ltd.
Sichuan Deyuan Pharmaceutical Group Co., Ltd.
Sichuan Shenghe Pharmaceutical Co., Ltd.
Tonghua Great Wall Pharmaceutical Co., Ltd.
Yabao Pharmaceutical Group Co., Ltd.
Yunnan Longfa Pharmaceutical Co., Ltd.
Yunpeng Pharmaceutical Group Co., Ltd.
Zhejiang Ruixin Pharmaceutical Co., Ltd.
Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Loratadine Tablets Segment by Type
20 mg/Tablet
40 mg/Tablet
60 mg/Tablet
Loratadine Tablets Segment by Application
Hospital
Pharmacy
Online e-commerce
Other
Loratadine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Loratadine Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loratadine Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Loratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Loratadine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
196 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Loratadine Tablets Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Loratadine Tablets Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Loratadine Tablets Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Loratadine Tablets Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Loratadine Tablets Market Dynamics
- 2.1 Loratadine Tablets Industry Trends
- 2.2 Loratadine Tablets Industry Drivers
- 2.3 Loratadine Tablets Industry Opportunities and Challenges
- 2.4 Loratadine Tablets Industry Restraints
- 3 Loratadine Tablets Market by Manufacturers
- 3.1 Global Loratadine Tablets Revenue by Manufacturers (2020-2025)
- 3.2 Global Loratadine Tablets Sales by Manufacturers (2020-2025)
- 3.3 Global Loratadine Tablets Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Loratadine Tablets Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Loratadine Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Loratadine Tablets Manufacturers, Product Type & Application
- 3.7 Global Loratadine Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Loratadine Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Loratadine Tablets Players Market Share by Revenue in 2024
- 3.8.3 2024 Loratadine Tablets Tier 1, Tier 2, and Tier 3
- 4 Loratadine Tablets Market by Type
- 4.1 Loratadine Tablets Type Introduction
- 4.1.1 20 mg/Tablet
- 4.1.2 40 mg/Tablet
- 4.1.3 60 mg/Tablet
- 4.2 Global Loratadine Tablets Sales by Type
- 4.2.1 Global Loratadine Tablets Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Loratadine Tablets Sales by Type (2020-2031)
- 4.2.3 Global Loratadine Tablets Sales Market Share by Type (2020-2031)
- 4.3 Global Loratadine Tablets Revenue by Type
- 4.3.1 Global Loratadine Tablets Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Loratadine Tablets Revenue by Type (2020-2031)
- 4.3.3 Global Loratadine Tablets Revenue Market Share by Type (2020-2031)
- 5 Loratadine Tablets Market by Application
- 5.1 Loratadine Tablets Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.1.3 Online e-commerce
- 5.1.4 Other
- 5.2 Global Loratadine Tablets Sales by Application
- 5.2.1 Global Loratadine Tablets Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Loratadine Tablets Sales by Application (2020-2031)
- 5.2.3 Global Loratadine Tablets Sales Market Share by Application (2020-2031)
- 5.3 Global Loratadine Tablets Revenue by Application
- 5.3.1 Global Loratadine Tablets Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Loratadine Tablets Revenue by Application (2020-2031)
- 5.3.3 Global Loratadine Tablets Revenue Market Share by Application (2020-2031)
- 6 Global Loratadine Tablets Sales by Region
- 6.1 Global Loratadine Tablets Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Loratadine Tablets Sales by Region (2020-2031)
- 6.2.1 Global Loratadine Tablets Sales by Region (2020-2025)
- 6.2.2 Global Loratadine Tablets Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Loratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Loratadine Tablets Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Loratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Loratadine Tablets Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Loratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Loratadine Tablets Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Loratadine Tablets Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Loratadine Tablets Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Loratadine Tablets Revenue by Region
- 7.1 Global Loratadine Tablets Revenue by Region
- 7.1.1 Global Loratadine Tablets Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Loratadine Tablets Revenue by Region (2020-2025)
- 7.1.3 Global Loratadine Tablets Revenue by Region (2026-2031)
- 7.1.4 Global Loratadine Tablets Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Loratadine Tablets Revenue (2020-2031)
- 7.2.2 North America Loratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Loratadine Tablets Revenue (2020-2031)
- 7.3.2 Europe Loratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Loratadine Tablets Revenue (2020-2031)
- 7.4.2 Asia-Pacific Loratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Loratadine Tablets Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Loratadine Tablets Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Anhui Guosen Pharmaceutical Co., Ltd.
- 8.1.1 Anhui Guosen Pharmaceutical Co., Ltd. Comapny Information
- 8.1.2 Anhui Guosen Pharmaceutical Co., Ltd. Business Overview
- 8.1.3 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Anhui Guosen Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.1.5 Anhui Guosen Pharmaceutical Co., Ltd. Recent Developments
- 8.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
- 8.2.1 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Comapny Information
- 8.2.2 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Business Overview
- 8.2.3 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.2.5 Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd. Recent Developments
- 8.3 Guangdong Hengcheng Pharmaceutical Co., Ltd.
- 8.3.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Comapny Information
- 8.3.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Business Overview
- 8.3.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.3.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments
- 8.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
- 8.4.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Comapny Information
- 8.4.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
- 8.4.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 8.4.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
- 8.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
- 8.5.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Comapny Information
- 8.5.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
- 8.5.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.5.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
- 8.6 Heilongjiang Nuojie Pharmaceutical Co., Ltd.
- 8.6.1 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Comapny Information
- 8.6.2 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Business Overview
- 8.6.3 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.6.4 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.6.5 Heilongjiang Nuojie Pharmaceutical Co., Ltd. Recent Developments
- 8.7 Hubei Minkang Pharmaceutical Co., Ltd.
- 8.7.1 Hubei Minkang Pharmaceutical Co., Ltd. Comapny Information
- 8.7.2 Hubei Minkang Pharmaceutical Co., Ltd. Business Overview
- 8.7.3 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.7.4 Hubei Minkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.7.5 Hubei Minkang Pharmaceutical Co., Ltd. Recent Developments
- 8.8 Hunan Erkang Pharmaceutical Co., Ltd.
- 8.8.1 Hunan Erkang Pharmaceutical Co., Ltd. Comapny Information
- 8.8.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
- 8.8.3 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.8.4 Hunan Erkang Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.8.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
- 8.9 Hunan Zhongnan Pharmaceutical Co., Ltd.
- 8.9.1 Hunan Zhongnan Pharmaceutical Co., Ltd. Comapny Information
- 8.9.2 Hunan Zhongnan Pharmaceutical Co., Ltd. Business Overview
- 8.9.3 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.9.4 Hunan Zhongnan Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.9.5 Hunan Zhongnan Pharmaceutical Co., Ltd. Recent Developments
- 8.10 Jilin Jinheng Pharmaceutical Co., Ltd.
- 8.10.1 Jilin Jinheng Pharmaceutical Co., Ltd. Comapny Information
- 8.10.2 Jilin Jinheng Pharmaceutical Co., Ltd. Business Overview
- 8.10.3 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.10.4 Jilin Jinheng Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.10.5 Jilin Jinheng Pharmaceutical Co., Ltd. Recent Developments
- 8.11 Sancai Shiqi Pharmaceutical Co., Ltd.
- 8.11.1 Sancai Shiqi Pharmaceutical Co., Ltd. Comapny Information
- 8.11.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
- 8.11.3 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.11.4 Sancai Shiqi Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.11.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
- 8.12 Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
- 8.12.1 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Comapny Information
- 8.12.2 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Business Overview
- 8.12.3 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.12.4 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 8.12.5 Shanxi Qianyuan Pharmaceutical Group Co., Ltd. Recent Developments
- 8.13 Shanxi Xinyu Pharmaceutical Co., Ltd.
- 8.13.1 Shanxi Xinyu Pharmaceutical Co., Ltd. Comapny Information
- 8.13.2 Shanxi Xinyu Pharmaceutical Co., Ltd. Business Overview
- 8.13.3 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.13.4 Shanxi Xinyu Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.13.5 Shanxi Xinyu Pharmaceutical Co., Ltd. Recent Developments
- 8.14 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
- 8.14.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Comapny Information
- 8.14.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
- 8.14.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.14.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 8.14.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
- 8.15 Sichuan Shenghe Pharmaceutical Co., Ltd.
- 8.15.1 Sichuan Shenghe Pharmaceutical Co., Ltd. Comapny Information
- 8.15.2 Sichuan Shenghe Pharmaceutical Co., Ltd. Business Overview
- 8.15.3 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.15.4 Sichuan Shenghe Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.15.5 Sichuan Shenghe Pharmaceutical Co., Ltd. Recent Developments
- 8.16 Tonghua Great Wall Pharmaceutical Co., Ltd.
- 8.16.1 Tonghua Great Wall Pharmaceutical Co., Ltd. Comapny Information
- 8.16.2 Tonghua Great Wall Pharmaceutical Co., Ltd. Business Overview
- 8.16.3 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.16.4 Tonghua Great Wall Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.16.5 Tonghua Great Wall Pharmaceutical Co., Ltd. Recent Developments
- 8.17 Yabao Pharmaceutical Group Co., Ltd.
- 8.17.1 Yabao Pharmaceutical Group Co., Ltd. Comapny Information
- 8.17.2 Yabao Pharmaceutical Group Co., Ltd. Business Overview
- 8.17.3 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.17.4 Yabao Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 8.17.5 Yabao Pharmaceutical Group Co., Ltd. Recent Developments
- 8.18 Yunnan Longfa Pharmaceutical Co., Ltd.
- 8.18.1 Yunnan Longfa Pharmaceutical Co., Ltd. Comapny Information
- 8.18.2 Yunnan Longfa Pharmaceutical Co., Ltd. Business Overview
- 8.18.3 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.18.4 Yunnan Longfa Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.18.5 Yunnan Longfa Pharmaceutical Co., Ltd. Recent Developments
- 8.19 Yunpeng Pharmaceutical Group Co., Ltd.
- 8.19.1 Yunpeng Pharmaceutical Group Co., Ltd. Comapny Information
- 8.19.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
- 8.19.3 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.19.4 Yunpeng Pharmaceutical Group Co., Ltd. Loratadine Tablets Product Portfolio
- 8.19.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
- 8.20 Zhejiang Ruixin Pharmaceutical Co., Ltd.
- 8.20.1 Zhejiang Ruixin Pharmaceutical Co., Ltd. Comapny Information
- 8.20.2 Zhejiang Ruixin Pharmaceutical Co., Ltd. Business Overview
- 8.20.3 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.20.4 Zhejiang Ruixin Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.20.5 Zhejiang Ruixin Pharmaceutical Co., Ltd. Recent Developments
- 8.21 Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
- 8.21.1 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Comapny Information
- 8.21.2 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Business Overview
- 8.21.3 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.21.4 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Loratadine Tablets Product Portfolio
- 8.21.5 Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Loratadine Tablets Value Chain Analysis
- 9.1.1 Loratadine Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Loratadine Tablets Production Mode & Process
- 9.2 Loratadine Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Loratadine Tablets Distributors
- 9.2.3 Loratadine Tablets Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
